HP
Hikari Power Portfolio holdings
AUM
$1.2B
This Quarter Return
+11.25%
1 Year Return
+14.18%
3 Year Return
+56.59%
5 Year Return
+122.08%
10 Year Return
+191.59%
AUM
$954M
AUM Growth
+$954M
(+7.4%)
Cap. Flow
-$21.6M
Cap. Flow
% of AUM
-2.27%
Top 10 Holdings %
Top 10 Hldgs %
55.57%
Holding
128
New
5
Increased
22
Reduced
13
Closed
5
Top Buys
| 1 |
Altria Group
MO
|
$5.56M |
| 2 |
AGN
Allergan plc
AGN
|
$2.32M |
| 3 |
Johnson & Johnson
JNJ
|
$2.14M |
| 4 |
Berkshire Hathaway Class A
BRK.A
|
$2.11M |
| 5 |
Vanguard FTSE Emerging Markets ETF
VWO
|
$1.82M |
Top Sells
| 1 |
Kraft Heinz
KHC
|
$8.89M |
| 2 |
RTX Corp
RTX
|
$7.35M |
| 3 |
Novo Nordisk
NVO
|
$4.75M |
| 4 |
Procter & Gamble
PG
|
$4.69M |
| 5 |
Cisco
CSCO
|
$2.92M |
Sector Composition
| 1 | Financials | 36.28% |
| 2 | Healthcare | 20.01% |
| 3 | Industrials | 12.08% |
| 4 | Technology | 6.87% |
| 5 | Consumer Staples | 6.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
AB InBev
BUD
$122B
| $10.4M | 1.09% | 123,800 | – | – |
|
27
Vanguard S&P 500 ETF
VOO
$726B
| $10.1M | 1.06% | 38,920 +6,330 | +19% | +$1.64M |
|
28
Colgate-Palmolive
CL
$67.9B
| $9.74M | 1.02% | 142,090 | – | – |
|
|
29
Altria Group
MO
$113B
| $8.34M | 0.87% | 145,190 +96,740 | +200% | +$5.56M |
|
30
Xtrackers Harvest CSI 300 China A-Shares ETF
ASHR
$2.34B
| $7.09M | 0.74% | 246,800 +62,300 | +34% | +$1.79M |
|
31
Amgen
AMGN
$155B
| $6.48M | 0.68% | 34,130 | – | – |
|
32
Vanguard Consumer Staples ETF
VDC
$7.6B
| $5.9M | 0.62% | 40,600 | – | – |
|
33
Becton Dickinson
BDX
$55.3B
| $5.69M | 0.6% | 22,800 | – | – |
|
34
US Bancorp
USB
$76B
| $5.62M | 0.59% | 116,700 | – | – |
|
|
35
Cisco
CSCO
$274B
| $5.61M | 0.59% | 103,900 -54,100 | -34% | -$2.92M |
|
36
Gilead Sciences
GILD
$140B
| $5.5M | 0.58% | 84,650 | – | – |
|
|
AKTX
37
Akari Therapeutics
AKTX
$24.8M
| $5.12M | 0.54% | 1,430,096 +230,399 | +19% | +$825K |
|
|
RDS.B
38
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
| $5.03M | 0.53% | 78,660 +10,060 | +15% | +$643K |
|
39
Medtronic
MDT
$119B
| $4.62M | 0.48% | 50,700 | – | – |
|
40
Cigna
CI
$80.3B
| $4.62M | 0.48% | 28,697 | – | – |
|
41
Alphabet (Google) Class C
GOOG
$2.58T
| $4.58M | 0.48% | 3,900 | – | – |
|
42
DaVita
DVA
$9.85B
| $4.07M | 0.43% | 74,880 -30,800 | -29% | -$1.67M |
|
|
43
Vanguard FTSE Emerging Markets ETF
VWO
$96.4B
| $4.04M | 0.42% | 94,930 +42,730 | +82% | +$1.82M |
|
44
Biogen
BIIB
$19.4B
| $3.37M | 0.35% | 14,260 | – | – |
|
|
CELG
45
DELISTED
Celgene Corp
CELG
| $3.34M | 0.35% | 35,370 -10,300 | -23% | -$972K |
|
|
SRCL
46
DELISTED
Stericycle Inc
SRCL
| $3.23M | 0.34% | 59,400 | – | – |
|
47
iShares Biotechnology ETF
IBB
$5.6B
| $3.18M | 0.33% | 28,440 +2,540 | +10% | +$284K |
|
48
Sanofi
SNY
$121B
| $3.15M | 0.33% | 71,190 -65,850 | -48% | -$2.92M |
|
49
AT&T
T
$209B
| $3.05M | 0.32% | 97,200 | – | – |
|
50
Bristol-Myers Squibb
BMY
$96B
| $2.96M | 0.31% | 62,080 | – | – |
|